A Tumor Suppressor-Regulated Cell Cycle Derived Gene Signature Is Prognostic Of Recurrence Risk In Prostate Cancer
C. Georgescu, J. M. Corbin, S. Thivibilliers, Z. D. Webb, Y. D. Zhao, J. Koster, K.-M. Fung, A. S. Asch, J. D. Wren, M. J. Ruiz Echevarria
The paper develops a gene signature based on Tmeff2-regulated cell cycle genes that predicts recurrence risk in prostate cancer and outperforms existing prognostic markers.
bioRxiv · Aug 21, 2018Cancer Biology